YU126791A - SUBSTITUTED PYROLY - Google Patents

SUBSTITUTED PYROLY

Info

Publication number
YU126791A
YU126791A YU126791A YU126791A YU126791A YU 126791 A YU126791 A YU 126791A YU 126791 A YU126791 A YU 126791A YU 126791 A YU126791 A YU 126791A YU 126791 A YU126791 A YU 126791A
Authority
YU
Yugoslavia
Prior art keywords
bond
sum
alkyl
together form
piq
Prior art date
Application number
YU126791A
Other languages
Serbo-Croatian (sh)
Other versions
YU47783B (en
Inventor
P.D. Davis
C.H. Hill
G. Lawton
Original Assignee
F.Hoffmann La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann La Roche Ag. filed Critical F.Hoffmann La Roche Ag.
Publication of YU126791A publication Critical patent/YU126791A/en
Publication of YU47783B publication Critical patent/YU47783B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Jedinjenja formule gde R1 i R3 zajedno formiraju vezu, a R2 predstavlja vodonik ili R1 i R2 zajedno formiraju vezu, a R3 predstavlja vodonik; R4, R5 R6 i R7 nezavisno jedan od drugog predstavljaju vodonik, halogen, alkil, haloalkil, alkoksi, nitro, amino, alkanoilamino, aroilamino, alkiltio ili alkil sulfonil; R8 predstavlja vodonik, alkil ili aralkil; X predstavlja -N(R9)-ili -CHN(R10, R11)-pri čemu svaki od R9, R10 i R11 predstavljaju vodonik, alkil, aralkil ili alkanoil; m znači 0-2, a n 1-3, uz uslov da suma m i n bude 1-3; p znači 0-4, a q 0-4, uz uslov da suma p i q bude 2-4 kada X predstavlja -N(R9)-, da suma p i q bude 1-5 kada X predstavlja - CHN(R10,R11)-, a R1 i R2 zajedno predstavljaju vezu da suma p i q bude 0-4 kada X predstavlja-CHN(R10,R11)-, a R1 i R3 zajedno formiraju vezu i da p bude 1-4 kada X predstavlja -N(R9)-, R1 i R3 zajedno čine vezu, a m znači O, kao i farmaceutski prihvatljive soli.Compounds of the formula wherein R 1 and R 3 together form a bond and R 2 represents hydrogen or R 1 and R 2 together form a bond and R 3 represents hydrogen; R 4, R 5, R 6 and R 7 independently of one another represent hydrogen, halogen, alkyl, haloalkyl, alkoxy, nitro, amino, alkanoylamino, aroylamino, alkylthio or alkyl sulfonyl; R8 represents hydrogen, alkyl or aralkyl; X represents -N (R9) -or -CHN (R10, R11) -where each of R9, R10 and R11 represent hydrogen, alkyl, aralkyl or alkanoyl; m means 0-2, and n 1-3, provided that the sum of m and n is 1-3; p means 0-4, aq 0-4, provided that the sum of piq is 2-4 when X represents -N (R9) -, that the sum of piq is 1-5 when X represents - CHN (R10, R11) -, and R1 and R2 together represent a bond that the sum of piq is 0-4 when X represents-CHN (R10, R11) -, and R1 and R3 together form a bond and that p is 1-4 when X represents -N (R9) -, R1 and R3 together form a bond, am means O, as well as pharmaceutically acceptable salts.

YU126791A 1990-08-07 1991-07-18 SUBSTITUTED PYROLES AND PROCEDURE FOR THEIR PRODUCTION YU47783B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909017269A GB9017269D0 (en) 1990-08-07 1990-08-07 Substituted pyrroles

Publications (2)

Publication Number Publication Date
YU126791A true YU126791A (en) 1994-01-20
YU47783B YU47783B (en) 1996-01-09

Family

ID=10680268

Family Applications (1)

Application Number Title Priority Date Filing Date
YU126791A YU47783B (en) 1990-08-07 1991-07-18 SUBSTITUTED PYROLES AND PROCEDURE FOR THEIR PRODUCTION

Country Status (5)

Country Link
BR (1) BR9103385A (en)
GB (1) GB9017269D0 (en)
MX (1) MX9100530A (en)
YU (1) YU47783B (en)
ZA (1) ZA916041B (en)

Also Published As

Publication number Publication date
GB9017269D0 (en) 1990-09-19
ZA916041B (en) 1992-04-29
YU47783B (en) 1996-01-09
MX9100530A (en) 1992-04-01
BR9103385A (en) 1992-05-12

Similar Documents

Publication Publication Date Title
ATE235470T1 (en) GASTRIN AND CCK ANTAGONISTS
MY106400A (en) Substituted pyrroles.
NO982330D0 (en) Pyrazole derivatives, processes for their preparation and pharmaceutical preparations containing said derivatives
NO960488D0 (en) Gastrin and CCK receptor ligands
DE3575130D1 (en) ANTI-INFLAMMATORY 1, N-DIARYLPYRAZOL-3-AMINE, THEIR COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF.
TR199900408T2 (en) 6kameli 6,6-Heterobisiklik t�revler.
NL1001124A1 (en) Bisacylphosphine oxides substituted with alkoxyphenyl.
ES2191208T3 (en) OXIIMINO-PREGNANO-CARBOLACTONAS.
TR199801734T2 (en) New arylglycinamide derivatives, production methods.
ES2079323B1 (en) DERIVATIVES OF INDOL USEFUL FOR THE TREATMENT OF THE MIGRAINE, COMPOSITION AND CORRESPONDING USE.
PE34297A1 (en) SPECIFIC LEAGUES OF NEUROPEPTIDE Y1
MY109337A (en) Phenoxyl-and phenoxyalkyl-piperidines as antiviral agents
MX9701195A (en) 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepin es.
NO995590D0 (en) 20-Aryl-5 <alpha> -pregnan derivatives
MY132550A (en) Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
TW340109B (en) Amide derivatives and their therapeutic use
MY131762A (en) Pharmaceutical compounds
ATE225335T1 (en) AMIDE DERIVATIVES AS 5-HT1A LIGANDS
UA41350C2 (en) Morpholine derivative or its pharmaceutically acceptable salt and pharmaceutical composition on its base
YU126791A (en) SUBSTITUTED PYROLY
MX9603199A (en) Endotheline receptors antagonists.
NO973340L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of obesity
UA41348C2 (en) Prodrugs of 3-acyl-2-oxindol-1-carboxamides and a pharmaceutical composition
ATE273284T1 (en) ARYLPHTALAZINE ANTAGONISTS OF EXITATONIC AMINO ACID RECEPTORS
SE9603284D0 (en) New compounds